GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 45 filers reported holding GALMED PHARMACEUTICALS LTD in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $4,111,000 | +38.1% | 860,103 | 0.0% | 0.30% | +9.3% |
| Q1 2020 | $2,976,000 | -58.3% | 860,103 | -11.5% | 0.27% | -59.6% |
| Q2 2019 | $7,139,000 | -10.0% | 971,337 | 0.0% | 0.67% | -15.4% |
| Q1 2019 | $7,936,000 | +19.6% | 971,337 | 0.0% | 0.79% | -6.6% |
| Q4 2018 | $6,634,000 | -42.6% | 971,337 | +14.1% | 0.85% | -27.3% |
| Q3 2018 | $11,563,000 | +22.6% | 851,492 | +7.4% | 1.16% | -4.1% |
| Q2 2018 | $9,433,000 | – | 792,707 | – | 1.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|